首页> 外文OA文献 >Gemtuzumab Ozogamicina: uma opção no tratamento de Leucemia mielóide aguda CD33+ Gemtuzumab Ozogamicin: an option in the treatment of acute myeloid leukemia CD33+

【2h】

Gemtuzumab Ozogamicina: uma opção no tratamento de Leucemia mielóide aguda CD33+ Gemtuzumab Ozogamicin: an option in the treatment of acute myeloid leukemia CD33+

机译：Gemtuzumab Ozogamycin：治疗急性髓性白血病CD33 + Gemtuzumab Ozogamycin的一种选择：治疗急性髓性白血病CD33 +的一种选择

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Celso M. Massumoto; Ronald F. Pinheiro; Edilson D. Pinheiro Júnior; Otávio C. Baiocchi; Adelson Alves;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Gemtuzumab Ozogamicina: uma op??o no tratamento de Leucemia mielóide aguda CD33+ [J] . Massumoto Celso M., Pinheiro Ronald F., Pinheiro Júnior Edilson D., Revista Brasileira de Hematologia e Hemoterapia . 2004 ,第4期

机译：吉姆单抗Ozogamycin：治疗急性髓细胞性白血病CD33 +的一种选择
2. Gemtuzumab Ozogamicin (CMA-676, Mylotarg) for the treatment of CD33+ acute myeloid leukemia. [J] . Voutsadakis IA Anti-cancer drugs . 2002 ,第7期

机译：Gemtuzumab Ozogamicin（CMA-676，Mylotarg）用于治疗CD33 +急性骨髓性白血病。
3. Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin [J] . IacobucciI., LonettiA., CandoniA., The pharmacogenomics journal . 2013 ,第4期

机译：用吉妥单抗-唑佐米星和氟达拉滨，阿糖胞苷和依达比星治疗的CD33 +急性髓性白血病患者的药物代谢酶/转运蛋白谱
4. Global Analysis of the Phosphoproteome of Human Blasts as a First Step to Discover Phosphorylation Biomarkers for the Treatment of Acute Myeloid Leukemia [C] . Heike Pfeifer, Felix Oppermann, Andreas Tebbe, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：对人类爆炸磷蛋白酶的全局分析作为发现磷酸化生物标志物治疗急性髓性白血病的第一步
5. Loss of Egr1 plays a role in murine leukemogenesis and may play a role in the development of acute myeloid leukemia and therapy-related acute myeloid leukemia. [D] . Joslin, John M. 2006

机译：Egr1的丢失在小鼠白血病的发生中起作用，并且可能在急性髓细胞性白血病和与治疗有关的急性髓细胞性白血病的发展中起作用。
6. Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukemia groups (AML-19) [O] . Sergio Amadori, Stefan Suciu, Dominik Selleslag, -1

机译：两次低剂量Gemtuzumab ozogamicin的随机试验作为新诊断的急性髓细胞白血病对老年患者的诱导单一的疗法而不是考虑到密集化疗的候选人。 EITTC和Gimema白血病组的II期研究（AML-19）
7. Gemtuzumab Ozogamicina: uma opção no tratamento de Leucemia mielóide aguda CD33+ Gemtuzumab Ozogamicin: an option in the treatment of acute myeloid leukemia CD33+ [O] . Celso M. Massumoto, Ronald F. Pinheiro, Edilson D. Pinheiro Júnior, 2004

机译：Gemtuzumab Ozogamycin：治疗急性髓性白血病CD33 + Gemtuzumab Ozogamycin的一种选择：治疗急性髓性白血病CD33 +的一种选择

Gemtuzumab Ozogamicina: uma opção no tratamento de Leucemia mielóide aguda CD33+ Gemtuzumab Ozogamicin: an option in the treatment of acute myeloid leukemia CD33+

著录项

相似文献

相关主题

期刊订阅